Clinical Trial Update: Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil [Phase 4]

View source ↗

Summary

Phase 4 prospective study at Kumamoto University evaluating oral nicorandil in patients with end-stage renal disease and coronary artery disease. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• End-stage Renal Disease

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Kumamoto University | Conditions: Coronary Artery Disease, End Stage Renal Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING